Alnylam Pharmaceuticals, Inc.
ALNY
$251.56
$8.953.69%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 10.46% | 15.54% | 27.56% | 14.52% | 11.27% |
| Total Receivables | 23.65% | 8.73% | 40.27% | 46.46% | 37.75% |
| Inventory | -11.93% | -20.66% | -16.40% | -28.73% | -30.87% |
| Prepaid Expenses | -7.45% | -7.98% | 6.39% | 69.67% | -4.92% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 10.48% | 12.39% | 25.71% | 17.61% | 10.79% |
|
|
|||||
| Total Current Assets | 10.48% | 12.39% | 25.71% | 17.61% | 10.79% |
| Net Property, Plant & Equipment | -4.39% | -3.52% | -2.83% | -2.59% | -1.74% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 106.57% | 17.40% | -14.61% | 3.55% | 5.12% |
| Total Assets | 10.71% | 9.53% | 17.85% | 12.75% | 7.99% |
|
|
|||||
| Total Accounts Payable | 59.25% | -4.11% | 23.82% | 25.57% | -43.40% |
| Total Accrued Expenses | 21.45% | 32.68% | 35.10% | 37.41% | 27.43% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 60.52% | 54.78% | 36.84% | 31.58% | 17.32% |
| Total Finance Division Other Current Liabilities | -8.22% | -7.92% | 26.30% | 114.70% | 118.25% |
| Total Other Current Liabilities | -8.22% | -7.92% | 26.30% | 114.70% | 118.25% |
| Total Current Liabilities | 22.58% | 28.52% | 33.81% | 39.85% | 26.03% |
|
|
|||||
| Total Current Liabilities | 22.58% | 28.52% | 33.81% | 39.85% | 26.03% |
| Long-Term Debt | 0.68% | 1.15% | 2.07% | 2.41% | 3.26% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -5.58% | -4.72% | -5.55% | -8.32% | -6.98% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -19.84% | -24.82% | -21.80% | 21.72% | 22.21% |
| Total Liabilities | 3.02% | 4.19% | 5.31% | 10.75% | 9.34% |
|
|
|||||
| Common Stock & APIC | 8.47% | 7.76% | 7.15% | 5.52% | 5.52% |
| Retained Earnings | -3.97% | -4.84% | -1.04% | -4.92% | -6.70% |
| Treasury Stock & Other | -47.67% | 23.23% | 6.59% | 31.02% | 47.65% |
| Total Common Equity | 130.41% | 119.51% | 99.25% | 15.42% | -39.45% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 130.41% | 119.51% | 99.25% | 15.42% | -39.45% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 130.41% | 119.51% | 99.25% | 15.42% | -39.45% |
|
|
|||||